EE03832B1 - Heptapeptiidanaloogid - Google Patents

Heptapeptiidanaloogid

Info

Publication number
EE03832B1
EE03832B1 EEP199900210A EE9900210A EE03832B1 EE 03832 B1 EE03832 B1 EE 03832B1 EE P199900210 A EEP199900210 A EE P199900210A EE 9900210 A EE9900210 A EE 9900210A EE 03832 B1 EE03832 B1 EE 03832B1
Authority
EE
Estonia
Prior art keywords
heptapeptide analogs
heptapeptide
analogs
Prior art date
Application number
EEP199900210A
Other languages
English (en)
Estonian (et)
Other versions
EE9900210A (et
Inventor
Melin Per
Nilsson Anders
A. Trojnar Jerzy
Aurell Carl-Johan
Riviere Pierre
Haigh Robert
Original Assignee
Ferring B.V.
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V., Ferring Ab filed Critical Ferring B.V.
Publication of EE9900210A publication Critical patent/EE9900210A/xx
Publication of EE03832B1 publication Critical patent/EE03832B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EEP199900210A 1996-11-26 1997-11-21 Heptapeptiidanaloogid EE03832B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604341A SE9604341D0 (sv) 1996-11-26 1996-11-26 Hepta-peptide oxytocin analogue
PCT/SE1997/001968 WO1998023636A1 (en) 1996-11-26 1997-11-21 Heptapeptide oxytocin analogues

Publications (2)

Publication Number Publication Date
EE9900210A EE9900210A (et) 1999-12-15
EE03832B1 true EE03832B1 (et) 2002-08-15

Family

ID=20404757

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900210A EE03832B1 (et) 1996-11-26 1997-11-21 Heptapeptiidanaloogid

Country Status (35)

Country Link
US (1) US6143722A (he)
EP (1) EP0938496B1 (he)
JP (1) JP3405460B2 (he)
KR (1) KR100463132B1 (he)
CN (1) CN1129606C (he)
AR (1) AR008531A1 (he)
AT (1) ATE242264T1 (he)
AU (1) AU713424B2 (he)
BR (1) BR9713366B1 (he)
CA (1) CA2272990C (he)
CZ (1) CZ299532B6 (he)
DE (1) DE69722651T2 (he)
DK (1) DK0938496T3 (he)
EE (1) EE03832B1 (he)
ES (1) ES2203823T3 (he)
HK (1) HK1022481A1 (he)
HR (1) HRP970630B1 (he)
HU (1) HU228568B1 (he)
IL (1) IL129519A (he)
LT (1) LT4650B (he)
LV (1) LV12350B (he)
MY (1) MY125555A (he)
NO (1) NO321380B1 (he)
NZ (1) NZ336445A (he)
PL (1) PL189292B1 (he)
PT (1) PT938496E (he)
RO (1) RO120772B1 (he)
RU (1) RU2180668C2 (he)
SE (1) SE9604341D0 (he)
SI (1) SI20026B (he)
SK (1) SK283800B6 (he)
TR (1) TR199901028T2 (he)
UA (1) UA54459C2 (he)
WO (1) WO1998023636A1 (he)
ZA (1) ZA9710518B (he)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US6476072B1 (en) * 2000-11-21 2002-11-05 Arthur Vanmoor Method of treating menstrual pain by enhancing the effectiveness of the human immune system
DE60309847T2 (de) * 2002-02-27 2007-10-18 Ferring B.V. Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
AU2003229735A1 (en) * 2002-05-02 2003-11-17 Bayer Aktiengesellschaft Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
EP1555029A1 (en) 2004-01-19 2005-07-20 Ferring B.V. Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
US20060171909A1 (en) * 2005-02-03 2006-08-03 The Procter & Gamble Company Cosmetic compositions comprising colorants with low free dye
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2695634C (en) 2007-08-06 2018-01-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
MX2010010743A (es) * 2008-03-31 2010-11-04 Ferring Bv Analogos de oxitocina.
DK3225250T3 (da) 2008-05-21 2019-11-04 Ferring Bv Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
EA030566B1 (ru) 2010-07-15 2018-08-31 Олег Ильич ЭПШТЕЙН Способ повышения терапевтической эффективности активированной-потенцированной формы антитела к эндогенной биомолекуле и фармацевтическая композиция
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
CN103415530A (zh) 2011-03-09 2013-11-27 Jitsubo株式会社 新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
CN102875650B (zh) * 2012-09-26 2014-06-11 深圳翰宇药业股份有限公司 巴卢西班的制备方法
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
EP3037101B1 (en) 2014-12-22 2019-03-06 Ferring B.V. Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
RU2726414C2 (ru) 2015-10-06 2020-07-14 Ферринг Б.В. Новые способы получения барусибана и его промежуточных соединений
KR20180099708A (ko) 2016-01-04 2018-09-05 메르크 세로노 에스. 에이. 하이드록시프로필티아졸리딘 카르복사미드 유도체의 알파-아미노 에스테르 및 이의 염 형태, 결정 다형체
ES2898778T3 (es) 2016-07-21 2022-03-08 ObsEva SA Pautas posológicas de antagonistas de oxitocina para promover la implantación de embriones y prevenir aborto espontáneo
CA3149898A1 (en) 2019-09-03 2021-03-11 Ernest Loumaye Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CN115380122A (zh) 2020-02-10 2022-11-22 奥布赛瓦股份公司 用于催产素受体拮抗剂疗法的生物标志物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2036973A1 (en) * 1990-02-27 1991-08-28 Mark G. Bock Cyclic hexapeptide oxytocin antagonists
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501678C2 (sv) * 1993-07-13 1995-04-10 Ferring Bv Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE523819C2 (sv) 1994-01-27 2004-05-18 Per-Ingvar Nilsson Accelerationsmunstycke samt metod för dess användning
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
SE9500249L (sv) 1995-01-25 1996-03-25 Valeo Engine Cooling Ab Värmeväxlartank med ändstycken, förfarande för framställning av en sådan tank, samt värmeväxlare försedd med en sådan

Also Published As

Publication number Publication date
LT4650B (lt) 2000-04-25
HUP0000577A2 (hu) 2000-11-28
DE69722651D1 (en) 2003-07-10
CN1129606C (zh) 2003-12-03
BR9713366B1 (pt) 2010-05-18
NO992532L (no) 1999-05-26
CZ299532B6 (cs) 2008-08-27
WO1998023636A1 (en) 1998-06-04
CZ183299A3 (cs) 2000-05-17
SI20026B (sl) 2000-06-30
BR9713366A (pt) 2000-01-25
RU2180668C2 (ru) 2002-03-20
PT938496E (pt) 2003-10-31
ES2203823T3 (es) 2004-04-16
HRP970630A2 (en) 1998-10-31
CN1238781A (zh) 1999-12-15
CA2272990C (en) 2002-11-19
LV12350B (en) 1999-11-20
MY125555A (en) 2006-08-30
ZA9710518B (en) 1998-06-10
JP2000507617A (ja) 2000-06-20
KR20000069045A (ko) 2000-11-25
HK1022481A1 (en) 2000-08-11
SI20026A (sl) 2000-02-29
DE69722651T2 (de) 2004-04-08
NZ336445A (en) 2000-06-23
NO992532D0 (no) 1999-05-26
NO321380B1 (no) 2006-05-02
IL129519A (he) 2004-09-27
CA2272990A1 (en) 1998-06-04
DK0938496T3 (da) 2003-10-06
PL189292B1 (pl) 2005-07-29
AU713424B2 (en) 1999-12-02
RO120772B1 (ro) 2006-07-28
IL129519A0 (en) 2000-02-29
SE9604341D0 (sv) 1996-11-26
EE9900210A (et) 1999-12-15
KR100463132B1 (ko) 2004-12-23
SK70499A3 (en) 2000-10-09
AR008531A1 (es) 2000-01-19
EP0938496B1 (en) 2003-06-04
ATE242264T1 (de) 2003-06-15
US6143722A (en) 2000-11-07
SK283800B6 (sk) 2004-02-03
HUP0000577A3 (en) 2001-02-28
LV12350A (lv) 1999-09-20
UA54459C2 (uk) 2003-03-17
LT99052A (en) 2000-01-25
HU228568B1 (en) 2013-04-29
HRP970630B1 (en) 2002-04-30
TR199901028T2 (xx) 1999-07-21
EP0938496A1 (en) 1999-09-01
AU5142998A (en) 1998-06-22
JP3405460B2 (ja) 2003-05-12

Similar Documents

Publication Publication Date Title
EE03832B1 (et) Heptapeptiidanaloogid
ID19403A (id) Senyawa-senyawa heterosiklik
ID19609A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID18090A (id) Mikrokapsul menggunakan iminooksadiazinadiona poliisosianat
ID15904A (id) Senyawa-senyawa tiofenopirimidina
ID19476A (id) Senyawa piridilpirol
ID19474A (id) Turunan tiazola
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
NO985680L (no) Peptidderivater
ID18095A (id) Turunan tetrahidrokinolin
BR9705635A (pt) Compostos
NO983849D0 (no) Peptidderivater
DK0923594T3 (da) Bromotiacumicinforbindelser
NO974125D0 (no) N-benzylazoliumderivater
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
DE29610959U1 (de) Präsent
DE29617236U1 (de) Befestigung
FI965275A0 (fi) Aonglaoda i kartong- eller pappersmaskin
KR970056542U (ko) 넥타이
KR970007831U (ko) 김밥 말이용 김발
NO983506D0 (no) Mellomkobling
FI3003U1 (fi) Kuormapankka
FI2674U1 (fi) Långnyppress i en pappers- eller kartongmaskin
FI960287A0 (fi) Anordning i avdammningsanlaeggning

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231